Myocardial infarction in diabetics: do thrombolytics help? - Syed, Uneeba
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Acute coronary artery disease (CAD) is one of the main cause of death in today's world. Myocardial infarction (MI) tends to be more common among diabetic patients. One of the most effective and used (in our settings) methods of resolution of MI is administration of streptokinase (SK). This study was conducted with the aim to determine the efficacy of thrombolytic therapy in reduction of ST segment elevation in acute MI patients presenting with diabetes.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Acute coronary artery disease (CAD) is one of the main cause of death in today's world. Myocardial infarction (MI) tends to be more common among diabetic patients. One of the most effective and used (in our settings) methods of resolution of MI is administration of streptokinase (SK). This study was conducted with the aim to determine the efficacy of thrombolytic therapy in reduction of ST segment elevation in acute MI patients presenting with diabetes.
Autorenporträt
Dr Uneeba Syed graduated from National University of Science and Technology. She has fellowship in general medicine, endocrinology and metabolism, is a clinical research certified professional and the author of quite a few research papers. Presently working as a consultant endocrinologist and physician in Tertiary Care Hospital in Lahore, Pakistan.